Mission Creek Capital Partners’s Eli Lilly LLY Stock Holding History

Mission Creek Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37M	Buy	3,666 +496	+16%	+$503K	0.67%	42
2025 Q4	$3.41M	Buy	3,170 +303	+11%	+$290K	0.69%	37
2025 Q3	$2.19M	Buy	2,867 +1,637	+133%	+$1.22M	0.43%	57
2025 Q2	$959K	Sell	1,230 -34	-3%	-$26.4K	0.21%	98
2025 Q1	$1.04M	Buy	1,264 +19	+2%	+$15.8K	0.25%	92
2024 Q4	$961K	Sell	1,245 -1,625	-57%	-$1.35M	0.21%	112
2024 Q3	$2.54M	Buy	2,870 +99	+4%	+$89K	0.59%	47
2024 Q2	$2.51M	Buy	2,771 +1,510	+120%	+$1.21M	0.63%	43
2024 Q1	$981K	Buy	+1,261	New	+$897K	0.26%	105

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mission Creek Capital Partners's LLY Position: Q1 2026 in Review

Mission Creek Capital Partners increased its Eli Lilly (LLY) stake by 16% in Q1 2026, buying an estimated $503K and bringing the position to 3,666 shares worth $3.37M. The position accounts for 0.67% of the portfolio, ranked #42.

Mission Creek Capital Partners first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.41M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Mission Creek Capital Partners held 3,666 shares of Eli Lilly worth $3.37M as of Q1 2026.
Mission Creek Capital Partners bought 496 Eli Lilly shares in Q1 2026, an estimated $503K.
Eli Lilly made up 0.67% of Mission Creek Capital Partners's portfolio in Q1 2026, its #42 holding.
Mission Creek Capital Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Mission Creek Capital Partners's Eli Lilly position peaked at $3.41M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mission Creek Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.